Skip to main content

Merck’s struggles with HPV vaccine send stock to worst selloff in almost 17 years

04 شباط 2025
Merck’s stock tumbled early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings.

For more details: Click here